Pioglitazone Improves Left Ventricular Diastolic Function in Patients With Essential Hypertension | Zendy

T. Horio | Zendy; Masayasu Suzuki | Zendy; Keita Suzuki | Zendy; Itaru Takamisawa | Zendy; Aki Hiuge | Zendy; Kei Kamide | Zendy; Shin Takiuchi | Zendy; Yoshio Iwashima | Zendy; Shinji Kihara | Zendy; T. Funahashi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pioglitazone Improves Left Ventricular Diastolic Function in Patients With Essential Hypertension

Author(s) -

T. Horio,

Masayasu Suzuki,

Keita Suzuki,

Itaru Takamisawa,

Aki Hiuge,

Kei Kamide,

Shin Takiuchi,

Yoshio Iwashima,

Shinji Kihara,

T. Funahashi

Publication year - 2005

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1016/j.amjhyper.2005.02.003

Subject(s) - medicine , pioglitazone , diastole , insulin resistance , cardiology , adiponectin , endocrinology , left ventricular hypertrophy , insulin , blood pressure , body mass index , diabetes mellitus , type 2 diabetes

Left ventricular (LV) hypertrophy and diastolic dysfunction, which are common cardiac consequences of hypertension, are modified by insulin resistance. The present study assessed the hypothesis that primary treatment of insulin resistance may reverse such cardiac changes in hypertensive patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research